Results 1 to 10 of about 9,286,915 (206)

New Insights Into CRASP-Mediated Complement Evasion in the Lyme Disease Enzootic Cycle

open access: yesFrontiers in Cellular and Infection Microbiology, 2020
Lyme disease (LD), which is caused by genospecies of the Borrelia burgdorferi sensu lato complex, is the most common vector-borne disease in the Northern hemisphere.
Yi-Pin Lin, Peter Kraiczy
exaly   +2 more sources

Genomic insights into the Ixodes scapularis tick vector of Lyme disease

open access: yesNature Communications, 2016
Ticks transmit more pathogens to humans and animals than any other arthropod. We describe the 2.1 Gbp nuclear genome of the tick, Ixodes scapularis (Say), which vectors pathogens that cause Lyme disease, human granulocytic anaplasmosis, babesiosis and ...
Jason M Meyer   +2 more
exaly   +2 more sources

What is the real number of Lyme disease cases in Canada?

open access: yesBMC Public Health, 2019
Background Lyme disease is emerging in Canada due to expansion of the range of the tick vector Ixodes scapularis from the United States. National surveillance for human Lyme disease cases began in Canada in 2009.
N. H. Ogden   +12 more
doaj   +2 more sources

Estimating the Frequency of Lyme Disease Diagnoses, United States, 2010–2018

open access: yesEmerging Infectious Diseases, 2021
By using commercial insurance claims data, we estimated that Lyme disease was diagnosed and treated in ≈476,000 patients in the United States annually during 2010–2018. Our results underscore the need for accurate diagnosis and improved prevention.
K. Kugeler   +4 more
semanticscholar   +1 more source

Comparison of Lyme Disease in the United States and Europe

open access: yesEmerging Infectious Diseases, 2021
Lyme disease, or Lyme borreliosis, is the most common tickborne disease in the United States and Europe. In both locations, Ixodes species ticks transmit the Borrelia burgdorferi sensu lato bacteria species responsible for causing the infection.
A. Marques, F. Strle, G. Wormser
semanticscholar   +1 more source

Economic Burden of Reported Lyme Disease in High-Incidence Areas, United States, 2014–2016

open access: yesEmerging Infectious Diseases, 2022
Approximately 476,000 cases of Lyme disease are diagnosed in the United States annually, yet comprehensive economic evaluations are lacking. In a prospective study among reported cases in Lyme disease–endemic states, we estimated the total patient cost ...
S. Hook   +13 more
semanticscholar   +1 more source

Recent Progress in Lyme Disease and Remaining Challenges

open access: yesFrontiers in Medicine, 2021
Lyme disease (also known as Lyme borreliosis) is the most common vector-borne disease in the United States with an estimated 476,000 cases per year. While historically, the long-term impact of Lyme disease on patients has been controversial, mounting ...
Jason R. Bobe   +30 more
semanticscholar   +1 more source

The year that shaped the outcome of the OspA vaccine for human Lyme disease

open access: yesnpj Vaccines, 2022
The expansion of Lyme borreliosis endemic areas and the corresponding increase of disease incidence have opened the possibility for greater acceptance of a vaccine.
R. Dattwyler, M. Gomes-Solecki
semanticscholar   +1 more source

Effect of Borrelia burgdorferi on the Expression of miRNAs in Breast Cancer and Normal Mammary Epithelial Cells

open access: yesMicroorganisms, 2023
Breast cancer is one of the leading causes of death in women worldwide. Recent studies have demonstrated that inflammation due to infections with microorganisms could play a role in breast cancer development.
Ananya Debbarma   +4 more
doaj   +1 more source

Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018

open access: yesEmerging Infectious Diseases, 2021
We evaluated MarketScan, a large commercial insurance claims database, for its potential use as a stable and consistent source of information on Lyme disease diagnoses in the United States.
Amy M Schwartz   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy